Showing results (111-120 of 756) with videos related to

Sort By:
Pageof 76
The Lancet. Gastroenterology & Hepatology|July 22, 2022
Safety and efficacy of liraglutide versus colesevelam for the treatment of bile acid diarrhoea: a randomised, double-blind, active-comparator, non-inferiority clinical trialMartin L Kårhus, Andreas Brønden, Julie L Forman, et al.
The Lancet. Gastroenterology & Hepatology|October 15, 2019
Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trialElisa Pose, Laura Napoleone, Ahmed Amin, et al.
The Lancet. Gastroenterology & Hepatology|June 20, 2018
Diagnostic accuracy of magnetic resonance enterography and small bowel ultrasound for the extent and activity of newly diagnosed and relapsed Crohn's disease (METRIC): a multicentre trialStuart A Taylor, Susan Mallett, Gauraang Bhatnagar, et al.
The Lancet. Gastroenterology & Hepatology|May 15, 2018
Misoprostol for small bowel ulcers in patients with obscure bleeding taking aspirin and non-steroidal anti-inflammatory drugs (MASTERS): a randomised, double-blind, placebo-controlled, phase 3 trialAli S Taha, Caroline McCloskey, Paula McSkimming, et al.
The Lancet. Gastroenterology & Hepatology|April 13, 2019
Optimisation of the use of APRI and FIB-4 to rule out cirrhosis in patients with chronic hepatitis B: results from the SONIC-B studyMilan J Sonneveld, Willem P Brouwer, Henry L-Y Chan, et al.
The Lancet. Gastroenterology & Hepatology|August 21, 2018
Endoscopic versus percutaneous biliary drainage in patients with resectable perihilar cholangiocarcinoma: a multicentre, randomised controlled trialRobert J S Coelen, Eva Roos, Jimme K Wiggers, et al.
The Lancet. Gastroenterology & Hepatology|January 27, 2023
Impact of hepatitis C virus point-of-care RNA viral load testing compared with laboratory-based testing on uptake of RNA testing and treatment, and turnaround times: a systematic review and meta-analysisAdam Trickey, Emmanuel Fajardo, Daniel Alemu, et al.
The Lancet. Gastroenterology & Hepatology|February 4, 2023
Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trialBrian G Feagan, Bruce E Sands, William J Sandborn, et al.
The Lancet. Gastroenterology & Hepatology|August 12, 2022
Prevalence of occult hepatitis B virus infection in adults: a systematic review and meta-analysisYu Ri Im, Rukmini Jagdish, Damien Leith, et al.
The Lancet. Gastroenterology & Hepatology|March 19, 2023
Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trialRohit Loomba, Manal F Abdelmalek, Matthew J Armstrong, et al.
Pageof 76